Navigation Links
Rheumatoid Arthritis Rising Among U.S. Women
Date:10/27/2008

Cases have increased since the mid-1990s, study shows

MONDAY, Oct. 27 (HealthDay News) -- The number of American women with rheumatoid arthritis (RA) is growing again after four decades of decline, according to a Mayo Clinic study.

The researchers tracked 350 adult patients, averaging 56.5 years of age, from Olmsted County, Minn. Of those patients, 69 percent were women.

In the United States, the incidence of RA had steadily declined from 1955 to 1994. But that changed in the mid-1990s, the study found. The Mayo researchers' analysis of data from early 1995 to the start of 2005 revealed that both the incidence and prevalence of RA were rising.

During those 10 years, the incidence of RA among women increased to 54 per 100,000, compared to 36 per 100,000 in the previous 10 years. The incidence of RA among men remained at about 29 per 100,000.

The rate of RA in the overall population increased from 0.85 percent to 0.95 percent.

The reason for the increase isn't clear, but environmental factors may play a role in the rise of the joint disease among women, the researchers suggested.

The study was to be presented at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals, in San Francisco.

More information

The Arthritis Foundation has more about rheumatoid arthritis.



-- Robert Preidt



SOURCE: Mayo Clinic, news release, Oct. 25, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
2. Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugais Actemra for Rheumatoid Arthritis
3. New Survey Findings Reveal Emotional and Physical Toll of Rheumatoid Arthritis and the Advancement of Treatment Through Generations
4. FDA Advisory Committee Recommends Approval of ACTEMRA(R) (tocilizumab) for the Treatment of Rheumatoid Arthritis
5. New Survey Findings Reveal Emotional and Physical Toll of Rheumatoid Arthritis and the Advancement of Treatment through "Generations"
6. High Birth Weight Doubles Risk of Rheumatoid Arthritis
7. Heavy birthweight increases risk of developing rheumatoid arthritis
8. Heavy birthweight babies twice as likely to develop rheumatoid arthritis
9. Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
10. Rheumatoid Arthritis Treatment Guidelines Updated
11. Rheumatoid Arthritis Drug Boosts Melanoma Incidence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Rheumatoid Arthritis Rising Among U.S. Women
(Date:4/29/2016)... Newport Beach, Calif. (PRWEB) , ... April 29, 2016 , ... ... affect us. An effective way to confront and deal with these stressors is to ... taste bad to be good for you. Risa Groux, a certified Holistic Nutritionist and ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... more flexibility in repaying their loans, more information about their loan terms and ... total outstanding student loan debt, including federal and private loans, has reached $1.3 ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Spine Team ... pain, is proud to announce one of their physicians has been invited to be ... Physicians (Texas ACOFP) Family Practice Review conference on April 30, 2016. , Dr. ...
(Date:4/29/2016)... ON (PRWEB) , ... April 29, 2016 , ... ... and the Canadian Celiac Association (CCA), is pleased to announce the launch of ... gluten-free products, nutritional articles, recipes, and more. The purpose of the GFCP ...
(Date:4/29/2016)... ... , ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a ... throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , ... patented safety device secured by nasal surgeons onto the floor of the nasal passages, ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)... , April 28, 2016 ... "Global Plastic Surgery Products Market 2016-2020" report ... ) , The global plastic surgery ... of 9.47% during the period 2016-2020. , ,The growing ... leading to the growth of the market. Lasers are ...
(Date:4/28/2016)... 28, 2016 Treato , ... healthcare, announced today that it has been named a ... Vendor in Life Sciences, 2016, Stephen Davies ... report focuses on life-science- oriented analytics, algorithms and smart ... and doctors, confirm medication ingestion, and analyze unstructured information. ...
Breaking Medicine Technology: